Name: ATTEST-2 demonstrated non-inferior efficacy and comparable safety data for Metalyse 25 mg compared to Actilyse1
Keywords: ATTEST-2 demonstrated non-inferior efficacy and comparable safety data for Metalyse 25 mg compared to Actilyse1

*
Farrington-Manning Score test.
†
An improvement of 8 or more points or a return to a total score of 0 or 1 points on the NIHSS.
‡
Data are n/N.

AD: absolute difference; CI: confidence interval; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; OR: odds ratio; sICH: symptomatic intracerebral haemorrhage.

Muir KW, et al. Lancet Neurol 2024;23:1087–1096 (including supplementary appendix).